FDA launches agency-wide scrutiny of clinical trials
This article was originally published in Clinica
The US FDA is consolidating its oversight of clinical trials with a series of likely reforms including a proposal requiring companies to notify the agency when they uncover falsified study results.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”